NNC 0151-0000-0000

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC 0151-0000-0000, covering 2014-08-15 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis [Phase 2]